CEFFECT 25 MG/ML SUSPENSION FOR INJECTION FOR CATTLE AND PIGS

国家: 爱尔兰

语言: 英文

来源: HPRA (Health Products Regulatory Authority)

有效成分:

CEFQUINOME (AS SULFATE)

可用日期:

Emdoka bvba

ATC代码:

QJ01DE90

INN（国际名称）:

CEFQUINOME (AS SULFATE)

剂量:

25 Mg/Ml

药物剂型:

Suspension for Injection

处方类型:

POM

治疗组:

Bovine, Porcine

治疗领域:

Cefquinome

疗效迹象:

Antibacterial

授权状态:

Authorised

授权日期:

2012-12-07

产品特点

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE VETERINARY MEDICINAL PRODUCT
Ceffect 25 mg/ml suspension for injection for cattle and pigs.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml
contains:
ACTIVE SUBSTANCE:
Cefquinome (as sulfate)
25 mg
EXCIPIENT(S):
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Suspension for injection.
White to slightly yellowish suspension.
4 CLINICAL PARTICULARS
4.1 TARGET SPECIES
Cattle and pigs.
4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For
the treatment
of
bacterial
infections
in cattle and pigs
caused by the Gram positive and Gram negative
microorganisms sensitive to cefquinome.
Cattle:
Respiratory disease caused by_ Pasteurella multocida_ and_ Mannheimia
haemolytica._
Digital dermatitis, infectious bulbar necrosis and acute interdigital
necrobacillosis (foul in the foot).
Acute_ E.coli_ mastitis with signs of systemic involvement.
Calves:
_E.coli_ septicaemia in calves.
Pigs:
For
the
treatment
of
bacterial
infections
of
the
lungs
and respiratory tract
caused by_ Pasteurella multocida,_
_Haemophilus_
_parasuis,_
_Actinobacillus_
_pleuropneumoniae,_
_Streptococcus_
_suis_
and
other
cefquinome-sensitive
organisms.
Mastitis-Metritis-Agalactia syndrome (MMA) with involvement of_
E.coli, Staphylococcus_ spp_., Streptococcus_ spp. and
other cefquinome sensitive organisms.
Piglets:
Reduction of mortality in cases of meningitis caused by_ Streptococcus
suis_.
For the treatment of:
Arthritis caused by_ Streptococcus_ spp_., E. coli_ and other
cefquinome-sensitive organisms.
Epidermitis (mild or moderate lesions) caused by_ Staphylococcus
hyicus._
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
__